Drug Shortage Report for APO-MOMETASONE
Report ID | 168418 |
Drug Identification Number | 02403587 |
Brand name | APO-MOMETASONE |
Common or Proper name | MOMETASONE |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | MOMETASONE FUROATE |
Strength(s) | 50MCG |
Dosage form(s) | SPRAY, METERED DOSE |
Route of administration | NASAL NASAL |
Packaging size | 140 MS |
ATC code | R01AD |
ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2022-08-29 |
Estimated end date | 2022-09-16 |
Actual end date | 2022-09-14 |
Shortage status | Resolved |
Updated date | 2022-09-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2022-09-15 | English | Compare |
v2 | 2022-09-01 | French | Compare |
v1 | 2022-09-01 | English | Compare |
Showing 1 to 3 of 3